Form 4: Mirum Pharmaceuticals SVP Discloses Routine Stock Transactions Following RSU Vesting
Insider Transaction Report
Mirum Pharmaceuticals' SVP, Global Controller, Jolanda Howe, reported the acquisition of common stock from restricted stock unit vesting and subsequent sales to cover tax obligations and under a pre-arranged trading plan.
Summary
- Jolanda Howe, SVP, Global Controller of Mirum Pharmaceuticals, Inc., acquired 1,041 shares of common stock on July 1, 2025, through the vesting of restricted stock units (RSUs).
- Each restricted stock unit represents a contingent right to receive one share of common stock.
- On July 2, 2025, 564 shares were sold at a price of $48.25 per share to cover tax withholding obligations associated with the RSU vesting.
- An additional 477 shares were sold on July 3, 2025, at a price of $49.08 per share, executed pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 16, 2024.
- Following these transactions, Jolanda Howe directly beneficially owns 2,426 shares of Mirum Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions (RSU vesting and subsequent sales for tax and pre-planned purposes), which are neutral in sentiment and do not indicate a change in company prospects or management confidence.
Stakeholder Impact
- Shareholders: The sale of shares by an executive, while routine for tax purposes and under a 10b5-1 plan, slightly reduces the executive's direct ownership percentage, though the overall impact on the company's share structure is minimal.
Key Dates
| Date | Description |
|---|---|
| 12/16/2024 | Date Rule 10b5-1 Plan was adopted by the reporting person. |
| 07/01/2025 | Date of RSU vesting and acquisition of 1,041 shares of common stock. |
| 07/02/2025 | Date of sale of 564 shares to cover tax withholding obligations. |
| 07/03/2025 | Date of sale of 477 shares under Rule 10b5-1 Plan and signature date of the filing. |
Keywords
Mirum Pharmaceuticals, MIRM, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Stock Sale, Rule 10b5-1 Plan, Jolanda Howe, SVP Global Controller
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.